Tirzepatide 30mg – Advanced Weight Management & Lifestyle Support | COA Verified

Tirzepatide 30MG is a premium high-concentration dual incretin receptor agonist extensively studied for its interaction with GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) pathways. It is widely explored in advanced metabolic and endocrine research involving glucose regulation, appetite signaling, and nutrient metabolism.

The 30MG format is engineered for high-demand laboratory applications, extended-duration studies, and large-scale experimental protocols requiring substantial peptide availability. Tirzepatide is commonly utilized in research focused on metabolic adaptation, adipose regulation, endocrine signaling, and long-term pathway analysis.

⚠️ For research and educational purposes only. Not for human consumption.

Product Highlights

✔ Maximum-strength 30MG peptide format
✔ Dual agonist peptide targeting GLP-1 & GIP pathways
✔ Designed for high-volume and long-duration research
✔ Supports advanced metabolic and endocrine studies
✔ Commonly explored in appetite signaling and body composition research
✔ Suitable for multi-phase and large-scale protocols
✔ High-purity peptide formulation (≥99%)
✔ COA Verified (Certificate of Analysis available)